Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Inspire Medical Systems Inc (INSP)

Inspire Medical Systems Inc (INSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,779,206
  • Shares Outstanding, K 29,056
  • Annual Sales, $ 802,800 K
  • Annual Income, $ 53,510 K
  • EBIT $ 37 M
  • EBITDA $ 34 M
  • 60-Month Beta 0.70
  • Price/Sales 3.44
  • Price/Cash Flow 57.32
  • Price/Book 4.27

Options Overview Details

View History
  • Implied Volatility 56.85% (-0.79%)
  • Historical Volatility 116.49%
  • IV Percentile 49%
  • IV Rank 32.33%
  • IV High 87.31% on 11/03/25
  • IV Low 42.30% on 02/11/25
  • Expected Move (DTE 22) 9.44 (9.86%)
  • Put/Call Vol Ratio 5.28
  • Today's Volume 226
  • Volume Avg (30-Day) 853
  • Put/Call OI Ratio 1.35
  • Today's Open Interest 9,655
  • Open Int (30-Day) 7,645
  • Expected Range 86.22 to 105.09

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 19 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.69
  • Number of Estimates 6
  • High Estimate 0.77
  • Low Estimate 0.61
  • Prior Year 1.15
  • Growth Rate Est. (year over year) -40.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
89.94 +6.35%
on 12/18/25
147.03 -34.95%
on 12/10/25
-21.64 (-18.45%)
since 11/24/25
3-Month
70.77 +35.16%
on 10/01/25
147.03 -34.95%
on 12/10/25
+17.82 (+22.90%)
since 09/24/25
52-Week
70.77 +35.16%
on 10/01/25
216.01 -55.72%
on 01/07/25
-90.64 (-48.66%)
since 12/24/24

Most Recent Stories

More News
INSP INVESTOR ALERT: $42.04 Stock Drop at Inspire Medical Systems (INSP) Triggers Securities Fraud Lawsuit Over Concealed Medicare Billing Software Failures & Inspire V Inventory Glut

Partner Reed Kathrein Urges Investors to Contact Firm Before January 5, 2026 Lead Plaintiff Deadline

INSP : 95.65 (+0.71%)
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that Inspire Medical Systems Investors Have Opportunity to Lead Class Action Lawsuit

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Inspire Medical To Contact Him Directly To Discuss Their Options

INSP : 95.65 (+0.71%)
Class Action Filed Against Inspire Medical Systems, Inc. (INSP) Seeking Recovery for Investors - Contact Levi & Korsinsky

NEW YORK , Dec. 23, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Inspire Medical Systems, Inc. ("Inspire Medical Systems, Inc." or the "Company") (NYSE: INSP) of a class action...

INSP : 95.65 (+0.71%)
INSP Investors Have Opportunity to Lead Inspire Medical Systems, Inc. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES , Dec. 22, 2025 /PRNewswire/ --  The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Inspire Medical...

INSP : 95.65 (+0.71%)
January 5, 2026 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against INSP

NEW YORK , Dec. 22, 2025 /PRNewswire/ --The Gross Law Firm issues the following notice to shareholders of Inspire Medical Systems, Inc. (NYSE: INSP).

INSP : 95.65 (+0.71%)
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Inspire Medical Systems

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Inspire Medical To Contact Him Directly To Discuss...

INSP : 95.65 (+0.71%)
INSP Deadline: INSP Investors with Losses in Excess of $100K Have Opportunity to Lead Inspire Medical Systems, Inc. Securities Fraud Lawsuit

NEW YORK , Dec. 20, 2025 /PRNewswire/ --

INSP : 95.65 (+0.71%)
Inspire Medical Systems, Inc. (INSP) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

BENSALEM, Pa. , Dec. 19, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action...

INSP : 95.65 (+0.71%)
INSP Shareholder Notice: $42.04 Stock Drop at Inspire Medical Systems (INSP) Triggers Securities Fraud Lawsuit Over Concealed Medicare Billing Software Failures & Inspire V Inventory Glut

Partner Reed Kathrein Urges Investors to Contact Firm Before January 5, 2026 Lead Plaintiff Deadline

INSP : 95.65 (+0.71%)
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of January 5, 2026 in Inspire Medical Systems, Inc. Lawsuit - INSP

NEW YORK , Dec. 19, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Inspire Medical Systems, Inc. ("Inspire Medical Systems, Inc." or the "Company") (NYSE: INSP) of a class action...

INSP : 95.65 (+0.71%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea....

See More

Key Turning Points

3rd Resistance Point 99.42
2nd Resistance Point 98.26
1st Resistance Point 96.95
Last Price 95.65
1st Support Level 94.49
2nd Support Level 93.33
3rd Support Level 92.02

See More

52-Week High 216.01
Fibonacci 61.8% 160.53
Fibonacci 50% 143.39
Fibonacci 38.2% 126.25
Last Price 95.65
52-Week Low 70.77

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar